World's Best Scientists 2026 revealed!
Frans Van de Werf

Frans Van de Werf

D-Index & Metrics

Medicine

D-Index
132
Citations
101727
World Ranking
2265
National Ranking
25

Frans Van de Werf publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Frans Van de Werf sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,127 publications — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Frans Van de Werf D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Frans Van de Werf sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 132 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Frans Van de Werf is affiliated with KU Leuven in Belgium and has contributed extensively to the field of medicine, with a particular focus on cardiology and cardiovascular medicine. Their scholarly work spans a range of topics including acute myocardial infarction research, cardiac imaging and diagnostics, coronary interventions and diagnostics, health systems and economic evaluations, antiplatelet therapy, heart failure treatment, and acute ischemic stroke management.

The scientist's research output includes publications primarily in the area of cardiology, with notable representation in peer-reviewed journals such as the European Heart Journal, Circulation, and American Heart Journal. They have published seven papers in the European Heart Journal, four in Circulation, three in the American Heart Journal, two in the European Heart Journal Acute Cardiovascular Care, and six through UNC Libraries.

Some recent publications authored or co-authored by Frans Van de Werf include:

  • STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial, 2023, Circulation
  • Polypill Strategy in Secondary Cardiovascular Prevention, 2022, New England Journal of Medicine
  • Veno-arterial extracorporeal membrane oxygenation (ECMO) in patients with cardiogenic shock: rationale and design of the randomised, multicentre, open-label EURO SHOCK trial, 2021, EuroIntervention
  • Implementing the new European Regulations on medical devices-clinical responsibilities for evidence-based practice: a report from the Regulatory Affairs Committee of the European Society of Cardiology, 2020, European Heart Journal
  • Impact of Complete Revascularization in the ISCHEMIA Trial, 2023, Journal of the American College of Cardiology

Frequent co-authors collaborating with Frans Van de Werf include:

  • Aldo P. Maggioni
  • Andrzej Budaj
  • Nicolas Danchin
  • Bernard Iung
  • Héctor Bueno

Frans Van de Werf's work is categorized mainly within medicine, with 87 publications overall. Specific subfields include cardiology and cardiovascular medicine (50 publications), surgery (12 publications), radiology, nuclear medicine and imaging (9 publications), economics and econometrics (8 publications), and epidemiology (5 publications).

Their research topics address various clinical and therapeutic aspects such as acute myocardial infarction, cardiac imaging, coronary interventions, health system evaluations, antiplatelet therapy, heart failure management, and ischemic stroke care, reflecting a multidisciplinary approach within cardiovascular and related medical sciences.

Best Publications

  • Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

    Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman

  • An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.

    Maarten Simoons;Eric Topol;Robert Califf;Frans van de Werf

  • Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist

  • Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both

    Marc A. Pfeffer;John J.V. McMurray;Eric J. Velazquez;Jean-Lucien Rouleau

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS).

    Marco Valgimigli;Héctor Bueno;Robert A Byrne;Jean-Philippe Collet

  • Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

    Jennifer B Green;M. Angelyn Bethel;Paul W Armstrong;John B Buse

  • Predictors of hospital mortality in the global registry of acute coronary events.

    Christopher B. Granger;Robert J. Goldberg;Omar Dabbous;Karen S. Pieper

  • Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

    Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt

  • 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

    Marco Valgimigli;Héctor Bueno;Robert A. Byrne;Jean-Philippe Collet

  • Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology.

    Frans Van de Werf;Diego Ardissino;Amadeo Betriu;Dennis V. Cokkinos

  • A validated prediction model for all forms of acute coronary syndrome:estimating the risk of 6-month postdischarge death in an international registry

    Kim A Eagle;Michael J Lim;Omar H Dabbous;Karen S Pieper

  • Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)

    Keith A A Fox;Omar H Dabbous;Robert J Goldberg;Karen S Pieper

  • Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial.

    Stefan Janssens;Christophe Dubois;Jan Bogaert;Koen Theunissen

  • Dabigatran versus Warfarin in Patients with Mechanical Heart Valves

    John W. Eikelboom;Stuart J. Connolly;Martina Brueckmann;Christopher B. Granger

  • Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

    Eric Boersma;Robert A Harrington;David J Moliterno;Harvey White

  • Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.

    Karen P. Alexander;L. Kristin Newby;Christopher P. Cannon;Paul W. Armstrong

  • Fibrinolysis or Primary PCI in ST-Segment Elevation Myocardial Infarction

    Paul W. Armstrong;Anthony H. Gershlick;Patrick Goldstein;Robert Wilcox

  • Evolving therapies for myocardial ischemia/reperfusion injury.

    Borja Ibáñez;Borja Ibáñez;Gerd Heusch;Michel Ovize;Frans Van de Werf

  • American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes. A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee).

    Christopher P Cannon;Alexander Battler;Ralph G Brindis;Jafna L Cox

  • Abciximab Facilitates the Rate and Extent of Thrombolysis Results of the Thrombolysis In Myocardial Infarction (TIMI) 14 Trial

    Elliott M. Antman;Robert P. Giugliano;C. Michael Gibson;Carolyn H. McCabe

Frequent Co-Authors

Paul W. Armstrong
Paul W. Armstrong University of Alberta
Christopher B. Granger
Christopher B. Granger Duke University
Harvey D. White
Harvey D. White Auckland City Hospital
Robert A. Harrington
Robert A. Harrington Cornell University
Robert M. Califf
Robert M. Califf Duke University
Kenneth W. Mahaffey
Kenneth W. Mahaffey Stanford University
L. Kristin Newby
L. Kristin Newby Duke University
Lars Wallentin
Lars Wallentin Uppsala University
Desire Collen
Desire Collen KU Leuven
Bart Bijnens
Bart Bijnens University of Barcelona

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and related fields can open many doors for those interested in the healthcare sector but not certain about pursuing a traditional medical degree. Programs like medical billing and coding schools that accept financial aid offer accessible entry points into healthcare administration, allowing students to begin their careers quickly and affordably.

For individuals drawn toward nursing, but worried about standardized testing, options such as absn programs that don't require teas remove common barriers and make the field more approachable. Additionally, if management roles appeal to you, an online healthcare management degree can prepare you for leadership positions across various medical settings.

Nurses with an associate degree can also advance their qualifications through asn to np programs, efficiently bridging the gap between entry-level and advanced practice roles. These pathways highlight the flexibility and diversity of online healthcare education, allowing students to tailor their journeys to suit their ambitions and circumstances.

Best Scientists Citing Frans Van de Werf

Trending Scientists

Recently Published Articles